|
STXBP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94089999627778E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.45340001040029E-09 |
| Normal-vs-Stage2 |
1.011850E-02 |
| Normal-vs-Stage3 |
2.90439999994785E-06 |
| Normal-vs-Stage4 |
5.458600E-01 |
| Stage1-vs-Stage2 |
4.559600E-01 |
| Stage1-vs-Stage3 |
4.581400E-01 |
| Stage1-vs-Stage4 |
2.130000E-01 |
| Stage2-vs-Stage3 |
7.810600E-01 |
| Stage2-vs-Stage4 |
3.610800E-01 |
| Stage3-vs-Stage4 |
3.085200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.74390002228142E-09 |
| Normal-vs-AfricanAmerican |
2.05589999999756E-05 |
| Normal-vs-Asian |
8.231700E-02 |
| Caucasian-vs-AfricanAmerican |
4.040400E-01 |
| Caucasian-vs-Asian |
3.012200E-01 |
| AfricanAmerican-vs-Asian |
5.802600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0550005313803E-11 |
| Normal-vs-Female |
1.236980E-03 |
| Male-vs-Female |
1.097660E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.809600E-04 |
| Normal-vs-Extreme_Weight |
3.22830651100503E-12 |
| Normal-vs-Obese |
8.80989999951787E-07 |
| Normal-vs-Extreme_Obese |
1.624190E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.689190E-01 |
| Normal_Weight-vs-Obese |
8.175800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.174200E-01 |
| Extreme_Weight-vs-Obese |
6.531800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.473400E-01 |
| Obese-vs-Extreme_Obese |
6.526000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.876400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.55996999999797E-05 |
| Normal-vs-Age(61-80Yrs) |
8.30229995862908E-09 |
| Normal-vs-Age(81-100Yrs) |
6.41240394116949E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.644400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.142200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.238800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.487700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.48089999999435E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.270040E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.98814314905849E-12 |
| Normal-VS-Type2 PRCC |
6.35540000000212E-05 |
| Normal-VS-KIRP CIMP |
1.582280E-02 |
| Normal-VS-Unclassified PRCC |
2.1990999999999E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.849600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.328040E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.023620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.931600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.409800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.225200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.63280003248911E-09 |
| Normal-vs-N1 |
4.986300E-02 |
| Normal-vs-N2 |
2.599800E-01 |
| N0-vs-N1 |
8.735800E-02 |
| N0-vs-N2 |
1.223440E-01 |
| N1-vs-N2 |
8.746600E-01 |
|
|
